Health & Fitness
Health and Fitness
Health and Fitness 
Thu, January 8, 2009
Sequenom to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 15
SAN DIEGO--([ BUSINESS WIRE ])--Sequenom, Inc. (NASDAQ: SQNM), a leading provider of genetic analysis solutions, today announced that Harry Stylli, Ph.D., President and Chief Executive Officer, is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference on Thursday, January 15th at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Westin St. Francis Hotel in San Francisco.
A live webcast of the presentation will be available on the Company's Web site at [ www.sequenom.com ], and replays will be available for 14 days starting approximately three hours after the initial presentation.
About Sequenom
Sequenom is committed to providing the best genetic analysis products that translate the results of genomic science into solutions for noninvasive prenatal diagnostics, biomedical research, translational research and molecular medicine applications. The Company's proprietary MassARRAY system is a high-performance (in speed, accuracy and cost efficiency) nucleic acid analysis platform that quantitatively and precisely measures genetic target material and variations. The Company has exclusively licensed intellectual property rights for the development and commercialization of noninvasive prenatal genetic tests for use with the MassARRAY® system and other platforms. For more information on Sequenom, please visit the Company's Web site at [ www.sequenom.com ].
Sequenom® and MassARRAY® are trademarks of Sequenom, Inc.